期刊文献+

鸡IL-2/NDV-F蛋白抗原表位融合基因的表达及免疫性初探

Fusion Expression and Immunity Evaluation of Chicken IL-2 with Antigen Epitopes from F Gene of Newcastle Disease Virus
下载PDF
导出
摘要 研究鸡白细胞介素-2(chicken interleukin-2,ChIL-2)的免疫佐剂功能,构建ChIL-2与新城疫病毒F蛋白多抗原表位(NDV-F)的嵌合基因,以对鸡新城疫疫病进行防治。采用重叠延伸PCR方法通过基因柔性接头将ChIL-2基因和NDV-F多抗原表位基因构建成ChIL-2-linker-NDV-F嵌合基因并克隆入PET-32a载体,经测序鉴定后,转化BL21大肠杆菌,IPTG诱导表达6×His融合蛋白,Ni2^+亲和柱纯化,表达产物经SDS-PAGE、Western blot和间接ELISA检测和鉴定。结果表明,实验成功构建并克隆了ChIL-2-linker-NDV-F嵌合基因,嵌合基因在大肠杆菌中表达的ChIL-2-linker-NDV-F融合蛋白分子量约为48kD,表达量约占菌体蛋白总量的45%,纯化后的ChIL-2-linker-NDV-F融合蛋白能与感染NDV的鸡血清发生反应。上述结果证明ChIL-2-linker-NDV-F嵌合基因在原核细胞中能有效表达,且融合蛋白具有较强的特异性和免疫原性。 To explore the immune adjuvant effects of chicken IL-2 (ChlL-2) , a recombinant plasmid with ChIL-2 and multi-antigen epitopes from F gene of Newcastle disease virus (NDV-F) was built and expressed in prokaryotic cells to prevent and control the chicken ND disease. The recombinant chimeric gene of ChlL-2-linker-NDV-F constructed by chicken ChlL-2 gene linked multi-antigen epitopes gene of NDV F protein via a serine-rich linker by overlap-PCR method was cloned into prokaryotic expression vector PET-32a. After identification by sequencing, the recombinant ChlL-2-inker-NDV-F protein was expressed in E. coli BI21 through IPTG and purified with the Ni2^+ affinity column. The expressed ChlL-2-linker-NDV-F protein was analyzed by SDS-PAGE, Western-blot and indirect ELISA, respectively. The chimeric gene of ChlL-2-linker-NDV-F was successfully constructed and cloned into PET-32a vector respectively. The expressed ChlL-2-linker-NDV-F protein was shown by a major band with a expected molecular weight about 48 kD on SDS-PAGE and Western-blot and accounted for almost 45 % of the total bacteria proteins, Serological assay by indirect ELISA showed that it reacted strongly and specifically with chicken serum of NDV infection. These results indieated that the chi- meric gene encoding Chll,-2-linker-NDV-F could effectively express in prokaryotic cells and the expressed protein had high specifieity and good irnmunogenicity.
出处 《激光生物学报》 CAS CSCD 2011年第2期230-235,共6页 Acta Laser Biology Sinica
基金 国家自然科学基金项目(30671537) 安徽农业大学博士启动基金项目(yj2009-26)
关键词 鸡IL-2基因 NDV-F蛋白 多抗原表位 融合蛋白 chicken lL-2 gene NDV-F protein multi-antigen epitopes fusion protein
  • 相关文献

参考文献20

  • 1TAGUCHI T.Interleukin-2(IL-2)[J].GanToKagakuRyoho,1994,21(5):719-724.
  • 2ROBAK T.Biological Propeaies and Therapeutic Use of Interleukin 2(IL-2)[J].Pestepy Higieny Medycyny Deswiadczalnej,1995,49(3):367-93.
  • 3PRENTICE H G,MACDONALD I D,HAMON M D.The Role of Immunotherapy in the Treatment of Acute Myeloblastic Ldukemia:from Allogeneic Bone Marrow Transplantation to the Appfication of Interleukin 2[J].Cancer Treatment and Research,1993,64:121-134.
  • 4REIER A,MrrsUYASU R T.Use of Intedeukin-2 in Immunotherapy of Human Immunedeficiency Vires Infection[J].Bio Drugs,1998,10(3):215-225.
  • 5SUNDICK R S,GILL-DIXON C.A Cloned Chicken Lymphokine Homologous to both Mammalian IL-2 and IL-15[J].J lmmunol,1997,159(2):720-725.
  • 6STEPANIAK J A,SHUSTER J E,HU W,et al.Production and in vitro Characterization of Recombinant Chicken Interleukin-2[J].Journal ofInterferon&Cytokine Research,1999,19(5):515-526.
  • 7TARPEY I,VAN LOON A A,DE HAAS N.A Recombinant Turkey Herpesvirus Expressing Chicken Intedeukin-2 Increases the Protection Provided by in viovo Vaccination with Infectious Bursal Disease and Infectious Bronchitis Virus[J].Vaccine,2007,25(51):8529-535.
  • 8TANG M,WANG H,ZHOU S,et al.Enhancement of the Immunogenicity of an Infectious Bronchitis Virus DNA Vaccine by a Bicistronic Plasmid Encoding Nucleacapsid Protein and Interleu kin-2[J].Journal ofVirologyMethods,2008,149(1):42-48.
  • 9HULSE D J,ROMER O C H.Partial Protection against Infectious Bursal Disease Virus through DNA-mediated Vaccination with the VP2 Capsid Protein and Chicken IL-2 Genes[J].Vaccine,2004,22(9/10):1249-1259.
  • 10闫若潜,谢彩华,吴志明,张志凌,刘光辉,刘梅芬.鸡α干扰素/白细胞介素2基因的融合表达及活性研究[J].中国农业科学,2010,43(3):594-604. 被引量:16

二级参考文献37

  • 1Meager A, Biological assays for interferons, Journal of Immunological Methods. 2002 261(1/2): 21-36.
  • 2Johnson H M, Bazer F W, Szente B E, Jarpe M A. How interferons fight disease. Scientific American, 1994, 270(5): 68-75.
  • 3Taguchi T. lnterleukin-2 (IL-2). Gan To Kagaku Rvoho 1994, 21(5): 719-724.
  • 4Tossing G. Interferon-alpha in treatment of chronic hepatitis C in co-infecled HIV-patients in combination with ribavirin and as a pre-load therapy in treatment-naive HIV-positive patients. 8th European Conference on clinical aspects and treatment of HIV infection (Sth ECCATH), 29-31 October, Athens Greece. European Journal of Medical Research, 2002, 7(1): 44-46.
  • 5Robak T. Biological properties and therapeutic use of interleukin 2 (IL-2). Postepy Higieny Medycyny Doswiadczabej, 1995, 49(3): 367-393.
  • 6Prentice H G, Macdonald 1 D, Hamon M D. The role of immunotherapy in the treatment of acute myeloblastic leukemia: from allogeneic bone marrow transplantation to the application of interleukin 2. Cancer Treatment and Research, 1993, 64:121-134.
  • 7Reier A, Mitsuyasu RT. Use of interleukin-2 in immunotherapy of human immunodeficiency virus infection. BioDrugs, 1998, 10(3): 215-225.
  • 8Sekellick M J, Ferrandino A IF, Hopkins D A, Marcus P I. Chicken interferon gene: cloning, expression, and analysis. Journal of lnterfervn Research, 1994, 14(2): 71-79.
  • 9Schultz U, Kaspers B, Rinderle C, Sekellick M J, Marcus P I, Staeheli E Recombinant chicken interferon: a potent antiviral agent that lacks intrinsic macrophage activating factor activity. European Journal of Immunology, 1995, 25(3): 847-851.
  • 10Jarosinski K W, Jia W, Sekellick M J, Marcus P I, Schat K A. Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek's disease virus expressing IFN-alpha. Journal of Interferon and Cytokine Research, 2001, 21(5): 287-296.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部